Success Metrics

Clinical Success Rate
100.0%

Based on 15 completed trials

Completion Rate
100%(15/15)
Active Trials
19(50%)
Results Posted
60%(9 trials)

Phase Distribution

Ph phase_1
1
3%
Ph not_applicable
1
3%
Ph phase_2
2
5%
Ph phase_3
16
42%
Ph phase_4
7
18%

Phase Distribution

1

Early Stage

2

Mid Stage

23

Late Stage

Phase Distribution27 total trials
Phase 1Safety & dosage
1(3.7%)
Phase 2Efficacy & side effects
2(7.4%)
Phase 3Large-scale testing
16(59.3%)
Phase 4Post-market surveillance
7(25.9%)
N/ANon-phased studies
1(3.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

15 of 15 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

19

trials recruiting

Total Trials

38

all time

Status Distribution
Active(22)
Completed(15)
Other(1)

Detailed Status

Completed15
Recruiting12
Active, not recruiting7
Not yet recruiting3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
38
Active
19
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (3.7%)
Phase 22 (7.4%)
Phase 316 (59.3%)
Phase 47 (25.9%)
N/A1 (3.7%)

Trials by Status

unknown13%
recruiting1232%
active_not_recruiting718%
not_yet_recruiting38%
completed1539%

Recent Activity

Clinical Trials (38)

Showing 20 of 38 trialsScroll for more
NCT06958315

Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study

Active Not Recruiting
NCT06813911Phase 3

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Recruiting
NCT06275724

Specified Drug-use Survey of Leqvio for s.c. Injection.

Active Not Recruiting
NCT07610278Phase 2

A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia

Recruiting
NCT06249165Phase 4

VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease

Active Not Recruiting
NCT06372925Phase 4

Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction

Active Not Recruiting
NCT06597006Phase 3

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Recruiting
NCT07615166

Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in Individuals Initiating Therapy in Routine Clinical Practice

Completed
NCT07684469Phase 4

Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia

Not Yet Recruiting
NCT06386419Phase 4

A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Completed
NCT07102628Phase 3

Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes

Recruiting
NCT07581808Phase 4

Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention

Recruiting
NCT05726838

The Belgian REAL (BE.REAL) Registry

Active Not Recruiting
NCT06597019Phase 3

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Recruiting
NCT05682378Phase 3

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

Recruiting
NCT03705234Phase 3

A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease

Active Not Recruiting
NCT05362903

A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

Completed
NCT05399992

Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD

Active Not Recruiting
NCT06287177

Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy

Recruiting
NCT04659863Phase 3

Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia

Completed

Drug Details

Intervention Type
DRUG
Total Trials
38